September 19, 2020

The Niche

Knoepfler lab stem cell blog

stem cell blinded

5 min read

Could the blinding of three women at a stem cell clinic have been prevented by better oversight or was the clinic acting outside of the scope of oversight by its institutional review board (IRB)? More broadly, when is an IRB conducting proper oversight and how do we know? When on the other hand is it not being careful enough or even outright enabling risky behavior by those selling non-FDA-approved, experimental stem cell “treatments”? It can be hard to really be sure. What makes this area particularly muddled …Read More